Life science company LGC announced today that it has acquired a majority stake in laboratory automation company Douglas Scientific.

Illumina published in April. 15 that $100 million will be invested to a new asset management company——Illumina Venture.

Organized by Sansure Biotech Inc. , the national demonstration center for genetic testing technology applications has been approved by NDRC and becomes

March 4, Ningbo MedicalSyetem Biotechnology Co., Ltd get the laboratory accreditation certificate of China National Accreditation Service for Conformity Assessment.

Jiangxi Huaxing established on Oct., 2005, is an earliest and largest integrated independent medical laboratory in Jiangxi province.

Financial department of social security deputy director Song Qichao today introduced that in 2016, the fiscal health expenditure budget will reach 1236.3 billion RMB,

Recently, Siemens Healthcare unveiled its new brand name Siemens Healthineers. The new brand underlines Siemens Healthcare's pioneering spirit and its engineering expertise in the healthcare industry.

Editas Medicine announced a three-year, $5 million agreement with Cystic Fibrosis Foundation Therapeutics recently, and Caribou Biosciences completed a $30 million Series B financing round.

Shenzhen Haplox Biotechnology Co., Ltd. is a hi-tech enterprise whom devoted itself into R&D and clinical application in ultromicro tumor genetic inspection,

China’s National Health and Family Planning Commission announced the final list of the first series of the national health insurance negotiation, while the oral targeted drug Erlotinib (Tarceva),

Recently, WuXi App Tec as well as WuXi NextCode, and Huawei jointly issued China's first Precision Medical Cloud platform in Shanghai.

On June 3rd, the big data company for tumor, Sipai Network announced that it has already finished tens of millions of dollars for B round financing in this week from Tencent Venture,

According to the CEO of Novartis, Joe Jimenez, Novartis may exit from the board of Roche without the premium, as long as the situation is allowed.

Illumina has sued Qiagen, alleging that the company's GeneReader next-generation sequencing instrument infringes on a patent Illumina holds related to sequencing

Under the banner of Greenery Group, Vela Diagnostics announced recently that, it is going to acquire the data analysis business of the cancer molecular diagnostic company lifecode,